ArticleEmerging infectious diseases2013
Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA.
Article in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Antimicrobial prescribing guidelines for horses in Australia.Australian veterinary journal · 2025Guideline
- Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia.Journal of veterinary internal medicine · 2015Trial
- Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.Journal of veterinary internal medicineTrial
- Anatomopathological aspects of osteoarticular lesions associated with Rhodococcus equi infection in two foals.Veterinary research communications · 2026Article
- Is Rifampin (Rifampicin) Essential for the Treatment of Rhodococcus equi Infections in Foals? A Critical Review of the Role of Rifampin.Journal of veterinary pharmacology and therapeutics · 2025Review
- Rifaximin resistance in Clostridioides difficile is associated with specific rpoB alleles and multilocus sequence typing (MLST) clades.BMC microbiology · 2025Article
- Antimicrobial Resistance in Equines: A Growing Threat to Horse Health and Beyond-A Comprehensive Review.Antibiotics (Basel, Switzerland) · 2024Review
- Article
- Antimicrobial Residue Accumulation Contributes to Higher Levels ofVeterinary sciences · 2024Article
- Article
- The Effects of Antimicrobial Protocols and Other Perioperative Factors on Postoperative Complications in Horses Undergoing Celiotomy: A Retrospective Analysis, 2008-2021.Animals : an open access journal from MDPI · 2023Article
- Antimicrobial susceptibility of Rhodococcus equi strains isolated from foals in Chile.World journal of microbiology & biotechnology · 2023Article
- Antimicrobial susceptibility of Rhodococcus equi strains isolated from foals in Chile.World journal of microbiology & biotechnology · 2023Article
- Less Typical Courses ofVeterinary sciences · 2022Article
- International Spread of Multidrug-Resistant Rhodococcus equi.Emerging infectious diseases · 2022Article
- Novel Quantitative PCR forAnimals : an open access journal from MDPI · 2022Article
- Fecal concentration of Rhodococcus equi determined by quantitative polymerase chain reaction of rectal swab samples to differentiate foals with pneumonia from healthy foals.Journal of veterinary internal medicine · 2022Article
- Antimicrobial resistance amongPeerJ · 2022Article
- Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.Journal of clinical microbiology · 2021Article
- Epidemiology and Molecular Basis of Multidrug Resistance in Rhodococcus equi.Microbiology and molecular biology reviews : MMBR · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macrolide and rifampin resistance developed on a horse breeding farm after widespread use was instituted for treatment of subclinical pulmonary lesions in foals. Resistance occurred in 6 (24%) of 25 pretreatment and 8 (62%) of 13 (62%) posttreatment isolates from affected foals. Drug-resistant isolates formed 2 distinct genotypic clusters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.